Notice ID: dd9fd0d7418d4f458170842f3423dbd6Sources SoughtArchived
FDA Licensed Ebola Virus Therapeutics
Archived on March 28, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM EDT
- Posted
- February 20, 2026
- Notice type
- Sources Sought
- Set-aside
- No Set aside used
- Agency
- Department of Health and Human ServicesOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Notice details
- Office
- BARDA - ASPR / DAAPPO / BARDA DCMA
- PSC
- 6505: DRUGS AND BIOLOGICALS
- Last updated
- Nov 3, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- BARDA-CBRN-022026
- Notice ID
- dd9fd0d7418d4f458170842f3423dbd6
Description
The Biomedical Advanced Research and Development Authority (BARDA), Administration for Strategic Preparedness and Response (ASPR) at the United States (U.S.) Department of Health and Human Services (HHS), is issuing this SSN to collect feedback from current and potential biopharmaceutical partners. Information collected from this SSN will serve as continued market research for possible future acquisitions and programs.
Award Overview
Contacts
Contracting Officer
Primary Contact
Yifan Yang
Secondary Contact
Justin Moore
Documents
Files (1)
- Download
Ebola virus_Therapeutic_SSN-BARDA-02202026.pdf
199 KBAdded in Sources Sought version 3Posted
Lifecycle
- 3Version 3Sources SoughtArchivedCurrent
FDA Licensed Ebola Virus Therapeutics
Similar Opportunities
Additional Details
Solicitation Number
BARDA-CBRN-022026
Archive Date
Mar 28, 2026
Office Address
WASHINGTON, DC, 20515